Glucagon-like peptide-1 receptor agonist use was associated with increased risk of telogen effluvium and androgenetic alopecia.

In adults with psoriasis, ustekinumab showed the highest drug survival rate in biologic-naive patients but had reduced effectiveness in biologic-experienced patients.

California, Colorado, Illinois, and Minnesota filed a lawsuit against the Trump administration for rescinding over $600 ...

The FDA issued a refuse-to-file letter for Moderna’s mRNA-based flu vaccine amid a shift toward stricter scrutiny of mRNA ...

Higher ultraprocessed food consumption was linked to higher rates of mortality after cancer diagnosis despite diet quality.

The severity of rosacea is significantly affected by 9 risk factors, including behavioral, demographic, and clinical characteristics.

Remibrutinib shows significant complete response rates across 3 chronic inducible urticaria subtypes in the phase 3 RemIND trial.

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

A proposed Oregon law aimed to cap THC in individual cannabis servings at 10 mg, following high rates of pediatric poisonings in 2023.

Patients with resected Merkel cell carcinoma residing in Medicaid expansion states had greater survival rates than those in nonexpansion states.

Patients in the pediatric intensive care unit who received high-risk rounds were less likely to incur a hospital-acquired condition.

Real-world study results showed that sonidegib was associated with greater treatment persistence than vismodegib at 12 months among adults with BCC.